[EN] ISOINDOLIN-1-ONE COMPOUNDS AS KINASE INHIBITORS<br/>[FR] COMPOSES D'ISOINDOLINE-1-ONE UTILISES EN TANT QU'INHIBITEURS DE KINASE
申请人:ABBOTT LAB
公开号:WO2004108672A1
公开(公告)日:2004-12-16
Compounds having the formula, (I) are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds and compositions containing the compounds.
Compounds having the formula
are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF
申请人:Boyd A. Vincent
公开号:US20070021434A1
公开(公告)日:2007-01-25
The present dislcosure provides amide-based, non-nucleoside compounds having antiviral activity against Hepacivirus, such as hepatitis C virus (HCV), methods and intermediates for synthesizing such compounds, and methods of using the compounds in a variety of contexts, including in the treatment and prevention of viral infections. The present dislcosure also provides methods for identifying amide-based, non-nucleoside compounds having antiviral activity.
COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE
申请人:Cameron Dale Russell
公开号:US20080171783A1
公开(公告)日:2008-07-17
The present disclosure provides amide-based, non-nucleoside compounds having an inhibitory activity against endogenous polymerases, such as polymerase alpha and polymerase gamma. This disclosure further provides uses of treating hyperproliferative diseases or disorders, such as benign or malignant neoplasms, and more specifically cancers that are sensitive to inhibition of polymerase alpha and polymerase gamma.
Compounds having the formula:
are useful for inhibiting protein kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.